Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> MULTIPLE SCLEROSIS Latest News

2 HOURS AGO - The Independent

A Must Read - Share

Thousands with degenerative conditions classified as 'fit to work in future' - despite no possibility of improvement

More than a third of people with degenerative conditions such as Parkinson’s and multiple sclerosis are having their benefits slashed because the Department for Work and Pensions deems they will recover enough to look for work.

Tags: Thousands with degenerative conditions classified as 'fit to work in future' - despite no possibility of improvement,  Multiple Sclerosis Latest News

7 HOURS AGO - Yahoo! News

A Must Read - Share

Biogen's Tecfidera sales miss estimates; confirms first PML case

By Bill Berkrot (Reuters) - Biogen Idec Inc said on Wednesday sales of its big-selling new multiple sclerosis drug Tecfidera fell short of Wall Street's lofty expectations, and the company confirmed a serious brain infection in a patient who took the oral medication, sending its shares 7 percent lower. Biogen reported the first case of progressive multifocal leukoencephalopathy (PML) in ...

Tags: Biogen's Tecfidera sales miss estimates; confirms first PML case,  Multiple Sclerosis Latest News

8 HOURS AGO - Washington Times

A Must Read - Share

Biogen slides as MS drug is linked to inflammation

CAMBRIDGE, Mass. (AP) - Shares of Biogen Idec slumped 8 percent Wednesday despite a strong quarter after the pharmaceutical said a patient who took its newest multiple sclerosis drug suffered a brain inflammation and later died. The company confirmed there was a case of progressive multifocal leukoencephalopathy, or ...

Tags: Biogen slides as MS drug is linked to inflammation,  Multiple Sclerosis Latest News

10 HOURS AGO - WebMD

A Must Read - Share

10 HOURS AGO - Yahoo! News

A Must Read - Share

Biogen shares down on Tecfidera sales, first confirmed PML case

By Bill Berkrot (Reuters) - Biogen Idec Inc on Wednesday reported sales of its big-selling new multiple sclerosis drug, Tecfidera, that fell short of Wall Street's lofty expectations, and the company confirmed a serious brain infection in a patient who took the oral medication, sending its shares about 8 percent lower. Biogen reported the first case of progressive multifocal leukoencephalopathy ...

Tags: Biogen shares down on Tecfidera sales, first confirmed PML case,  Multiple Sclerosis Latest News